NK cells for cancer immunotherapy
2020 · Nature Reviews Drug Discovery · 1,184 citations
https://doi.org/10.1038/s41573-019-0052-1
N
Noriko Shimasaki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
4.5K
Citations
24
h-index
32
i10-index
Noriko Shimasaki is an academic researcher from National University of Singapore. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & Infection Control and Ventilation. The author has an h-index of 24, co-authored 76 publications.
ORCID: 0000-0002-6506-2291Papers by this author
worksGermline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
2009 · Journal of Clinical Oncology · 349 citations
https://doi.org/10.1200/jco.2008.20.4156
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
2014 · Blood · 172 citations
https://doi.org/10.1182/blood-2014-02-556837
ISSCR standards for the use of human stem cells in basic research
2023 · Stem Cell Reports · 90 citations
https://doi.org/10.1016/j.stemcr.2023.08.003
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
2020 · Clinical Cancer Research · 65 citations
https://doi.org/10.1158/1078-0432.ccr-20-0768
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat